https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Comparing saliva and blood for the detection of mosaic genomic abnormalities that cause syndromic intellectual disability https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51840 Wed 20 Sep 2023 16:11:26 AEST ]]> Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54830 Fri 15 Mar 2024 11:53:47 AEDT ]]>